Gisselbrecht M, Eliaszewicz M, Pialoux G, Janssen B, Fleury J, Gonzalez G, Feuillie V, Dupont B
Service de Maladies infectieuses, Hôpital de l'Institut Pasteur, Paris.
Presse Med. 1995 Mar 11;24(10):474-8.
Investigate the rate of infection in HIV positive patients with an implantable venous access device.
Forty-six totally implantable venous access devices (port-a-cath, PAC) were inserted in 46 HIV infected patients between January 1990 and May 1992. We analyzed the rate of infectious complications and tried to find predictive factors.
There were five infectious complications in five patients. The total complication rate was 0.06 per 100 catheter days. Staphylococcus aureus was responsible in two cases, Staphylococcus epidermidis was responsible in one case and Acinetobacter in one case. No predictive factor was recognized.
The rate of PAC infection was lower than in other published studies concerning HIV-infected patients. Totally implantable central venous access devices play an increasingly important role in the clinical management of HIV-related diseases. We have shown that the PAC device is safe and convenient in HIV-infected patients.
调查植入式静脉通路装置在HIV阳性患者中的感染率。
1990年1月至1992年5月期间，46例HIV感染患者植入了46个完全植入式静脉通路装置（输液港，PAC）。我们分析了感染并发症的发生率，并试图找出预测因素。
5例患者出现5次感染并发症。总并发症发生率为每100导管日0.06次。2例由金黄色葡萄球菌引起，1例由表皮葡萄球菌引起，1例由不动杆菌引起。未发现预测因素。
PAC感染率低于其他关于HIV感染患者的已发表研究。完全植入式中心静脉通路装置在HIV相关疾病的临床管理中发挥着越来越重要的作用。我们已经证明，PAC装置在HIV感染患者中是安全且方便的。
